These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1553 related articles for article (PubMed ID: 19249105)

  • 1. Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study.
    Bares M; Kopecek M; Novak T; Stopkova P; Sos P; Kozeny J; Brunovsky M; Höschl C
    J Affect Disord; 2009 Nov; 118(1-3):94-100. PubMed ID: 19249105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Priming stimulation enhances the effectiveness of low-frequency right prefrontal cortex transcranial magnetic stimulation in major depression.
    Fitzgerald PB; Hoy K; McQueen S; Herring S; Segrave R; Been G; Kulkarni J; Daskalakis ZJ
    J Clin Psychopharmacol; 2008 Feb; 28(1):52-8. PubMed ID: 18204341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study.
    Rumi DO; Gattaz WF; Rigonatti SP; Rosa MA; Fregni F; Rosa MO; Mansur C; Myczkowski ML; Moreno RA; Marcolin MA
    Biol Psychiatry; 2005 Jan; 57(2):162-6. PubMed ID: 15652875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QEEG Theta Cordance in the Prediction of Treatment Outcome to Prefrontal Repetitive Transcranial Magnetic Stimulation or Venlafaxine ER in Patients With Major Depressive Disorder.
    Bares M; Brunovsky M; Novak T; Kopecek M; Stopkova P; Sos P; Höschl C
    Clin EEG Neurosci; 2015 Apr; 46(2):73-80. PubMed ID: 24711613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
    J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shorter duration of depressive episode may predict response to repetitive transcranial magnetic stimulation.
    Holtzheimer PE; Russo J; Claypoole KH; Roy-Byrne P; Avery DH
    Depress Anxiety; 2004; 19(1):24-30. PubMed ID: 14978782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled study of sequentially applied repetitive transcranial magnetic stimulation in obsessive-compulsive disorder.
    Kang JI; Kim CH; Namkoong K; Lee CI; Kim SJ
    J Clin Psychiatry; 2009 Dec; 70(12):1645-51. PubMed ID: 19709504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial.
    George MS; Lisanby SH; Avery D; McDonald WM; Durkalski V; Pavlicova M; Anderson B; Nahas Z; Bulow P; Zarkowski P; Holtzheimer PE; Schwartz T; Sackeim HA
    Arch Gen Psychiatry; 2010 May; 67(5):507-16. PubMed ID: 20439832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcranial magnetic stimulation in treatment-resistant depressed patients: a double-blind, placebo-controlled trial.
    Rossini D; Lucca A; Zanardi R; Magri L; Smeraldi E
    Psychiatry Res; 2005 Nov; 137(1-2):1-10. PubMed ID: 16225930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
    Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
    Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of response to repetitive transcranial magnetic stimulation (rTMS) in major depression: replication study in drug-free patients.
    Brakemeier EL; Wilbertz G; Rodax S; Danker-Hopfe H; Zinka B; Zwanzger P; Grossheinrich N; Várkuti B; Rupprecht R; Bajbouj M; Padberg F
    J Affect Disord; 2008 May; 108(1-2):59-70. PubMed ID: 17963846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A sham-controlled trial of the efficacy and safety of twice-daily rTMS in major depression.
    Loo CK; Mitchell PB; McFarquhar TF; Malhi GS; Sachdev PS
    Psychol Med; 2007 Mar; 37(3):341-9. PubMed ID: 17176505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venlafaxine for treatment-resistant unipolar depression.
    Nierenberg AA; Feighner JP; Rudolph R; Cole JO; Sullivan J
    J Clin Psychopharmacol; 1994 Dec; 14(6):419-23. PubMed ID: 7884023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repetitive transcranial magnetic stimulation in combination with citalopram in young patients with first-episode major depressive disorder: a double-blind, randomized, sham-controlled trial.
    Huang ML; Luo BY; Hu JB; Wang SS; Zhou WH; Wei N; Hu SH; Xu Y
    Aust N Z J Psychiatry; 2012 Mar; 46(3):257-64. PubMed ID: 22391283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial with 4-month follow-up of adjunctive repetitive transcranial magnetic stimulation of the left prefrontal cortex for depression.
    Mogg A; Pluck G; Eranti SV; Landau S; Purvis R; Brown RG; Curtis V; Howard R; Philpot M; McLoughlin DM
    Psychol Med; 2008 Mar; 38(3):323-33. PubMed ID: 17935639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial.
    Bretlau LG; Lunde M; Lindberg L; Undén M; Dissing S; Bech P
    Pharmacopsychiatry; 2008 Mar; 41(2):41-7. PubMed ID: 18311683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unilateral low frequency versus sequential bilateral repetitive transcranial magnetic stimulation: is simpler better for treatment of resistant depression?
    Pallanti S; Bernardi S; Di Rollo A; Antonini S; Quercioli L
    Neuroscience; 2010 May; 167(2):323-8. PubMed ID: 20144692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentative repetitive navigated transcranial magnetic stimulation (rTMS) in drug-resistant bipolar depression.
    Dell'Osso B; Mundo E; D'Urso N; Pozzoli S; Buoli M; Ciabatti M; Rosanova M; Massimini M; Bellina V; Mariotti M; Altamura AC
    Bipolar Disord; 2009 Feb; 11(1):76-81. PubMed ID: 19133969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson's disease: a randomized, double-blind, placebo-controlled study.
    Pal E; Nagy F; Aschermann Z; Balazs E; Kovacs N
    Mov Disord; 2010 Oct; 25(14):2311-7. PubMed ID: 20740485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 78.